Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Aberrant Expression of Anaplastic Lymphoma Kinase in Ovarian Carcinoma Independent of Gene RearrangementTang, Shaoxian ; Yang, Fei ; Du, Xiang ; Lu, Yongming ; Zhang, Ling ; Zhou, XiaoyanInternational journal of gynecological pathology, 2016-07, Vol.35 (4), p.337-347 [Periódico revisado por pares]United States: International Society of Gynecological PathologistsTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Absence of estrogen receptor-α expression in human ovarian clear cell adenocarcinoma compared with ovarian serous, endometrioid, and mucinous adenocarcinomaFUJIMURA, Masaki ; HIDAKA, Takao ; KATAOKA, Ken ; YAMAKAWA, Yoshihiro ; AKADA, Shinobu ; TERANISHI, Akiko ; SAITO, ShigeruThe American journal of surgical pathology, 2001-05, Vol.25 (5), p.667-672 [Periódico revisado por pares]Hagerstown, MD: Lippincott Williams & WilkinsTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Advances in precision therapy of low-grade serous ovarian cancer: A reviewWang, Qing ; Cao, Sheng-Han ; Li, Yan-Yu ; Zhang, Jing-Bo ; Yang, Xin-Hui ; Zhang, BeiMedicine (Baltimore), 2024-04, Vol.103 (17), p.e34306-e34306 [Periódico revisado por pares]United StatesTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Allelic Imbalance on Chromosome 17p13 in Borderline (Low Malignant Potential) Epithelial Ovarian TumorsZanotti, Kristine M ; Hart, William R ; Kennedy, Alexander W ; Belinson, Jerome L ; Casey, GrahamInternational journal of gynecological pathology, 1999-07, Vol.18 (3), p.247-253 [Periódico revisado por pares]Philadelphia, PA: International Society of Gynecological PathologistsTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Alteration of Telomerase Activity Associated With Development and Extension of Epithelial Ovarian CancerOishi, Tetsuro ; Kigawa, Junzo ; Minagawa, Yukihisa ; Shimada, Muneaki ; Takahashi, Masakuni ; Terakawa, NaokiObstetrics and gynecology (New York. 1953), 1998-04, Vol.91 (4), p.568-571 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Alterations in Expression Pattern of Splicing Factors in Epithelial Ovarian Cancer and its Clinical ImpactIborra, Severine ; Hirschfeld, Marc ; Jaeger, Markus ; zur Hausen, Axel ; Braicu, Iona ; Sehouli, Jalid ; Gitsch, Gerald ; Stickeler, ElmarInternational journal of gynecological cancer, 2013-07, Vol.23 (6), p.990-996 [Periódico revisado por pares]England: Copyright by IGCS and ESGOTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancerBruchim, I. ; Fishman, A. ; Friedman, E. ; Goldberg, I. ; Chetrit, A. ; Barshack, I. ; Dekel, E. ; Hirsh‐Yechezkel, G. ; Modan, B. ; Kopolovic, J.International journal of gynecological cancer, 2004-03, Vol.14 (2), p.251-258 [Periódico revisado por pares]Oxford, UK; Malden, USA: Blackwell Science IncTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Annexin IV is Differentially Expressed in Clear Cell Carcinoma of the OvaryMiao, Yi ; Cai, Bin ; Liu, Ling ; Yang, Yixia ; Wan, XiaopingInternational journal of gynecological cancer, 2009-12, Vol.19 (9), p.1545-1549 [Periódico revisado por pares]England: Copyright by IGCS and ESGOTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Applying Precision Medicine to Ovarian Cancer: Proof-of-Principle for a “Molecular Second Look”Schwartz, Melissa ; Camacho-Vanegas, Olga ; Wood, Ashley M ; Dashkoff, Matthew ; Whitelock, Courtney ; Harkins, Timothy T ; Cohen, Carmel J ; Beddoe, Ann Marie ; Dottino, Peter ; Martignetti, John AInternational journal of gynecological cancer, 2018-03, Vol.28 (3), p.479-485 [Periódico revisado por pares]England: by the International Gynecologic Cancer Society and the European Society of Gynaecological OncologyTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistanceSALANI, R. ; KURMAN, R.J. ; GIUNTOLI, R. ; GARDNER, G. ; BRISTOW, R. ; WANG, T.‐L. ; SHIH, I.‐M.International journal of gynecological cancer, 2008-05, Vol.18 (3), p.487-491 [Periódico revisado por pares]Malden, USA: Blackwell Publishing IncTexto completo disponível |